Skadden advised Vertex Pharmaceuticals Incorporated on the deal while Cooley represented ViaCyte. Vertex Pharmaceuticals Incorporated (“Vertex”) has entered into a definitive agreement under which Vertex will acquire...
Vertex’s $320 Million Acquisition of ViaCyte
Abnormal Security’s $210 Million Series C Financing Round
Cooley advised Abnormal Security on the deal. Abnormal Security, a leading artificial intelligence-based cloud-native email security platform, announced its $210 million Series C financing round, which...
2C2P’s Partnership with Ant Group
Cooley advised 2C2P on the deal. 2C2P, a global payments platform, announced its strategic partnership with Ant Group, an innovative technology provider that strives to bring the...
Route’s $200 Million Series B Financing Round
Cooley advised Route on the deal. Route, a post-purchase experience platform and package tracking company, announced its $200 million Series B financing round, which brings its valuation...
Hazel’s Merger Agreements with Even and ONE
Wachtell, Lipton, Rosen and Katz represented Even in the transaction. Hazel, the independent fintech launched in partnership with Walmart and fintech investment firm Ribbit Capital, has...
Groww’s $83 Million Series D Financing Round
Cooley LLP advised Groww on the deal, and AZB & Partners advised investor Tiger Global Management Bangalore-based Groww, an online investment platform, announced its $83 million Series...